Cost-effectiveness of precision medicine in oncology setting in China: protocol for a systematic review and meta-analysis

Introduction The past decade has witnessed significant advancements in genome-targeted oncology drugs within the realm of precision medicine (PM). However, the cost-effectiveness of oncology PM in a highly populated, low- and middle-income country such as China remains uncertain, particularly due to...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Jiang, Wenjia Chen, Huan Li, Dongni Zheng, Shunlong Ou
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/7/e093416.full
Tags: Add Tag
No Tags, Be the first to tag this record!